News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Morphic Therapeutic
Morphic to Participate in Jefferies Global Healthcare Conference
May 31, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Demonstrates Novel Real-Time Visualization of Small Molecule α4β7 Inhibition of Gut-Trafficking Cells
May 21, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Participate in RBC Capital Markets Global Healthcare Conference
May 09, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024
April 25, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Appoints Dr. Simon Cooper as Chief Medical Officer
March 19, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Participate in March Investor Conferences
March 05, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2023
February 22, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present at November Investor Conferences
November 10, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Announces Corporate Highlights and Financial Results for the Third Quarter 2023
November 03, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Therapeutic to Host Webcast to Present EMERALD-1 Full Data Set
October 09, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Holdings Announces CEO Dr. Praveen Tipirneni to Take Temporary Medical Leave of Absence
September 26, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present Positive EMERALD-1 Phase 2a Data for MORF-057 in Patients with Moderate to Severe Ulcerative Colitis in Abstract for UEGW 2023
September 22, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Announces Participation in 2023 Wells Fargo Healthcare Conference
August 29, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present at the Canaccord Genuity 43rd Annual Growth Conference
August 09, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2023
August 03, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present at the Jefferies Global Healthcare Conference
June 06, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference
May 12, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis
May 11, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Therapeutic Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 05, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Therapeutic Announces Pricing of $240.0 Million Public Offering
May 03, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Therapeutic Announces Proposed Public Offering
May 02, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Reports Positive Topline Results of the EMERALD-1 UC Main Cohort; Orally Administered MORF-057 Achieves Primary Endpoint and Demonstrates Clinically Meaningful Improvements Across Secondary and Exploratory Measures
April 25, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2023
April 25, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Therapeutic to Host EMERALD-1 Topline Results Call on April 25, 2023
April 24, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present at TD Cowen 43rd Annual Health Care Conference
March 03, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Announces Corporate Highlights and Financial Results for the Full Year 2022
February 23, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present at SVB Leerink Global Healthcare Conference
February 14, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Morphic Announces Initiation of EMERALD-2 Phase 2b Clinical Trial of MORF-057 in Patients with Moderate-to-Severe Ulcerative Colitis
November 22, 2022
From
Morphic Therapeutic
Via
GlobeNewswire
Tickers
MORF
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.